ID
15375
Beskrivning
Study documentation part: Concomitant medication Study short name: DIMAT MS Study Details: A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on ImmuneModulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis. Principal Investigator PD Dr. Luisa Klotz, University Hospital Münster EudraCT - No.: 2014-003481-25. Clinical Trial No.: NCT02461069. Please list below concomitant medications which are taken within a period from 30 days prior to Screening until the end of the study participation. Please list below signi cant non-drug therapies which are performed over the course of study participation.
Nyckelord
Versioner (2)
- 2016-05-28 2016-05-28 -
- 2016-05-28 2016-05-28 -
Uppladdad den
28 maj 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Concomitant medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis DRKS00008037 NCT02461069
Concomitant medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis NCT02461069
Beskrivning
Signature
Similar models
Concomitant medication, DIMAT-MS Relapsing Remitting Multiple Sclerosis NCT02461069
C0599938 (UMLS CUI [2])
C0011008 (UMLS CUI [1,2])